ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -86.5% | 10,618 | -80.1% | 0.00% | – |
| Q2 2023 | $74 | -51.0% | 53,346 | -44.2% | 0.00% | – |
| Q1 2023 | $151 | -82.6% | 95,594 | -31.4% | 0.00% | -100.0% |
| Q4 2022 | $868 | -99.7% | 139,427 | +841.9% | 0.00% | – |
| Q3 2021 | $316,000 | +0.3% | 14,802 | -0.7% | 0.00% | – |
| Q2 2021 | $315,000 | +88.6% | 14,902 | +150.2% | 0.00% | – |
| Q1 2021 | $167,000 | -37.2% | 5,956 | -41.9% | 0.00% | – |
| Q4 2020 | $266,000 | -61.1% | 10,260 | -44.2% | 0.00% | -100.0% |
| Q3 2020 | $683,000 | -31.4% | 18,384 | -5.3% | 0.00% | -50.0% |
| Q2 2020 | $995,000 | -24.9% | 19,411 | -53.8% | 0.00% | 0.0% |
| Q1 2020 | $1,325,000 | +137.5% | 42,052 | +348.7% | 0.00% | +100.0% |
| Q4 2019 | $558,000 | +158.3% | 9,373 | +58.8% | 0.00% | 0.0% |
| Q3 2019 | $216,000 | -71.2% | 5,901 | -63.4% | 0.00% | -50.0% |
| Q2 2019 | $750,000 | +47.1% | 16,141 | +27.0% | 0.00% | +100.0% |
| Q1 2019 | $510,000 | -19.6% | 12,708 | -7.8% | 0.00% | -50.0% |
| Q4 2018 | $634,000 | +291.4% | 13,785 | +276.9% | 0.00% | +100.0% |
| Q3 2018 | $162,000 | +67.0% | 3,657 | +46.4% | 0.00% | – |
| Q2 2018 | $97,000 | +15.5% | 2,498 | +115.0% | 0.00% | -100.0% |
| Q1 2018 | $84,000 | -57.4% | 1,162 | -70.5% | 0.00% | -50.0% |
| Q3 2017 | $197,000 | +4825.0% | 3,943 | +3843.0% | 0.01% | – |
| Q2 2017 | $4,000 | -99.6% | 100 | -99.6% | 0.00% | -100.0% |
| Q1 2017 | $958,000 | +435.2% | 27,155 | +89.2% | 0.04% | +272.7% |
| Q4 2016 | $179,000 | -20.4% | 14,353 | -12.0% | 0.01% | -26.7% |
| Q3 2016 | $225,000 | +389.1% | 16,315 | +243.8% | 0.02% | +400.0% |
| Q2 2016 | $46,000 | -9.8% | 4,745 | +55.7% | 0.00% | -25.0% |
| Q1 2016 | $51,000 | -79.9% | 3,048 | -73.3% | 0.00% | -80.0% |
| Q4 2015 | $254,000 | -65.6% | 11,412 | +26.2% | 0.02% | -67.7% |
| Q2 2015 | $739,000 | +7.7% | 9,041 | +22.0% | 0.06% | -22.5% |
| Q1 2015 | $686,000 | – | 7,410 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |